🧬 Rising Oncology Drug Costs Are Hurting Your Bottom Line — Here's How to Fight Back

Oncology practices face an uphill battle: cutting-edge cancer treatments come with soaring drug costs, delayed reimbursements, and ever-changing billing regulations. The result? Strained cash flow, tighter margins, and a constant balancing act between patient care and financial health.

In our latest blog, we dive into real-world, actionable strategies that can help you:
✅ Reduce drug acquisition costs through smarter inventory and pricing
✅ Leverage biosimilars, GPOs, and assistance programs to cut expenses
✅ Maximize reimbursement with accurate coding and RCM expertise
✅ Explore revenue-boosting options like the 340B program and value-based care models

💰 Whether you're managing a large oncology group or a solo practice, these strategies are built to protect your revenue—without compromising patient outcomes.

📖 [Read the full blog] and discover how Confair helps oncologists improve financial performance while focusing on what matters most: saving lives.